|
Iris Oifigiúil |
GA Sraith C |
|
C/2026/3946 |
17.7.2026 |
Achoimre ar chinntí an Aontais Eorpaigh maidir le húdaruithe margaíochta i ndáil le táirgí íocshláinte ó 1 Meitheamh 2026 go dtí 30 Meitheamh 2026
(Arna fhoilsiú de bhun Airteagal 13 nó Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle (1) nó Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle (2) )
(C/2026/3946)
— Údarú margaíochta a eisiúint (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
ANI (an tAinm Neamhdhílseánaigh Idirnáisiúnta) |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Foirm chógaisíochta |
An Cód CAT (an Cód Ceimiceach Teiripeach Anatamaíoch) |
Dáta an fhógra |
||
|
4 Meitheamh 2026 |
Retsevmo |
selpercatinib |
|
EU/1/20/1527 |
Capsúl, crua |
L01EX22 |
5.6.2026 |
||
|
19.6.2026 |
Cenrifki |
tolebrutinib |
|
EU/1/25/2011 |
Piolla brataithe le scannán |
L04AA62 |
22.6.2026 |
||
|
19.6.2026 |
Palbociclib Viatris |
palbociclib |
|
EU/1/26/2039 |
Piolla brataithe le scannán |
L01EF01 |
22.6.2026 |
||
|
19.6.2026 |
Redemplo |
plozasiran |
|
EU/1/26/2041 |
Tuaslagán le haghaidh insteallta |
Pending |
22.6.2026 |
||
|
19.6.2026 |
Rexatilux |
Ranibizumab |
|
EU/1/26/2043 |
Solution for injection in a pre-filled syringe Tuaslagán le haghaidh insteallta |
S01LA04 |
25.6.2026 |
||
|
30.6.2026 |
Itvisma |
onasemnogene abeparvovec |
|
EU/1/26/2038 |
Tuaslagán le haghaidh insteallta |
M09AX09 |
1.7.2026 |
— Údarú margaíochta a eisiúint (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Diúltaithe
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
12.6.2026 |
Iloperidone Vanda Pharmaceuticals |
|
- |
18.6.2026 |
— Údarú margaíochta a mhodhnú (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
3.6.2026 |
Lojuxta |
|
EU/1/13/851 |
5.6.2026 |
||
|
4.6.2026 |
Ahzantive |
|
EU/1/24/1888 |
8.6.2026 |
||
|
4.6.2026 |
Anzupgo |
|
EU/1/24/1851 |
8.6.2026 |
||
|
4.6.2026 |
Cholestagel |
|
EU/1/03/268 |
9.6.2026 |
||
|
4.6.2026 |
Enbrel |
|
EU/1/99/126 |
5.6.2026 |
||
|
4.6.2026 |
JEMPERLI |
|
EU/1/21/1538 |
9.6.2026 |
||
|
4.6.2026 |
RINVOQ |
|
EU/1/19/1404 |
5.6.2026 |
||
|
4.6.2026 |
Sarclisa |
|
EU/1/20/1435 |
5.6.2026 |
||
|
4.6.2026 |
Zejula |
|
EU/1/17/1235 |
9.6.2026 |
||
|
8.6.2026 |
Aucatzyl |
|
EU/1/25/1951 |
9.6.2026 |
||
|
8.6.2026 |
Pirfenidone Viatris |
|
EU/1/22/1707 |
9.6.2026 |
||
|
11.6.2026 |
Alkindi |
|
EU/1/17/1260 |
16.6.2026 |
||
|
11.6.2026 |
Aripiprazole Zentiva |
|
EU/1/15/1009 |
12.6.2026 |
||
|
11.6.2026 |
Doptelet |
|
EU/1/19/1373 |
18.6.2026 |
||
|
11.6.2026 |
Elaprase |
|
EU/1/06/365 |
15.6.2026 |
||
|
11.6.2026 |
Emtricitabine/Tenofovir disoproxil Mylan |
|
EU/1/16/1133 |
12.6.2026 |
||
|
11.6.2026 |
Ofev |
|
EU/1/14/979 |
30.6.2026 |
||
|
11.6.2026 |
Qoyvolma |
|
EU/1/25/1925 |
13.6.2026 |
||
|
11.6.2026 |
Repaglinide Accord |
|
EU/1/11/743 |
12.6.2026 |
||
|
11.6.2026 |
Repaglinide Teva |
|
EU/1/09/530 |
12.6.2026 |
||
|
11.6.2026 |
RINVOQ |
|
EU/1/19/1404 |
12.6.2026 |
||
|
11.6.2026 |
Riximyo |
|
EU/1/17/1184 |
22.6.2026 |
||
|
11.6.2026 |
Voxzogo |
|
EU/1/21/1577 |
22.6.2026 |
||
|
12.6.2026 |
Alkindi |
|
EU/1/17/1260 |
16.6.2026 |
||
|
12.6.2026 |
Dazublys |
|
EU/1/25/1949 |
19.6.2026 |
||
|
12.6.2026 |
Dyrupeg |
|
EU/1/25/1914 |
19.6.2026 |
||
|
12.6.2026 |
Faslodex |
|
EU/1/03/269 |
15.6.2026 |
||
|
12.6.2026 |
Lorviqua |
|
EU/1/19/1355 |
15.6.2026 |
||
|
12.6.2026 |
Rezzayo |
|
EU/1/23/1775 |
15.6.2026 |
||
|
12.6.2026 |
Rozlytrek |
|
EU/1/20/1460 |
15.6.2026 |
||
|
12.6.2026 |
TALVEY |
|
EU/1/23/1748 |
15.6.2026 |
||
|
12.6.2026 |
TECVAYLI |
|
EU/1/22/1675 |
15.6.2026 |
||
|
12.6.2026 |
Xbryk |
|
EU/1/24/1889 |
17.6.2026 |
||
|
12.6.2026 |
Xigduo |
|
EU/1/13/900 |
15.6.2026 |
||
|
12.6.2026 |
Zefylti |
|
EU/1/24/1899 |
19.6.2026 |
||
|
19.6.2026 |
Alunbrig |
|
EU/1/18/1264 |
23.6.2026 |
||
|
19.6.2026 |
Braftovi |
|
EU/1/18/1314 |
22.6.2026 |
||
|
19.6.2026 |
Columvi |
|
EU/1/23/1742 |
22.6.2026 |
||
|
19.6.2026 |
Constella |
|
EU/1/12/801 |
22.6.2026 |
||
|
19.6.2026 |
Fluenz |
|
EU/1/24/1816 |
22.6.2026 |
||
|
19.6.2026 |
Gardasil 9 |
|
EU/1/15/1007 |
22.6.2026 |
||
|
19.6.2026 |
Gotenfia |
|
EU/1/25/2009 |
23.6.2026 |
||
|
19.6.2026 |
HETRONIFLY |
|
EU/1/24/1870 |
22.6.2026 |
||
|
19.6.2026 |
Icandra |
|
EU/1/08/484 |
22.6.2026 |
||
|
19.6.2026 |
Inaqovi |
|
EU/1/23/1756 |
23.6.2026 |
||
|
19.6.2026 |
Kesimpta |
|
EU/1/21/1532 |
22.6.2026 |
||
|
19.6.2026 |
KEYTRUDA |
|
EU/1/15/1024 |
22.6.2026 |
||
|
19.6.2026 |
Maviret |
|
EU/1/17/1213 |
22.6.2026 |
||
|
19.6.2026 |
Memantine Mylan |
|
EU/1/13/827 |
22.6.2026 |
||
|
19.6.2026 |
Mysimba |
|
EU/1/14/988 |
22.6.2026 |
||
|
19.6.2026 |
Ngenla |
|
EU/1/21/1617 |
22.6.2026 |
||
|
19.6.2026 |
Ontozry |
|
EU/1/21/1530 |
22.6.2026 |
||
|
19.6.2026 |
Opzelura |
|
EU/1/23/1726 |
23.6.2026 |
||
|
19.6.2026 |
Padcev |
|
EU/1/21/1615 |
22.6.2026 |
||
|
19.6.2026 |
Palynziq |
|
EU/1/19/1362 |
29.6.2026 |
||
|
19.6.2026 |
Poteligeo |
|
EU/1/18/1335 |
23.6.2026 |
||
|
19.6.2026 |
QUVIVIQ |
|
EU/1/22/1638 |
3.7.2026 |
||
|
19.6.2026 |
Rezdiffra |
|
EU/1/25/1962 |
22.6.2026 |
||
|
19.6.2026 |
Rixathon |
|
EU/1/17/1185 |
22.6.2026 |
||
|
19.6.2026 |
Rizmoic |
|
EU/1/18/1291 |
2.7.2026 |
||
|
19.6.2026 |
Skyrizi |
|
EU/1/19/1361 |
22.6.2026 |
||
|
19.6.2026 |
Spherox |
|
EU/1/17/1181 |
30.6.2026 |
||
|
19.6.2026 |
Vipdomet |
|
EU/1/13/843 |
23.6.2026 |
||
|
19.6.2026 |
Zessly |
|
EU/1/18/1280 |
23.6.2026 |
||
|
19.6.2026 |
Zomarist |
|
EU/1/08/483 |
22.6.2026 |
||
|
22.6.2026 |
Trodelvy |
|
EU/1/21/1592 |
23.6.2026 |
||
|
25.6.2026 |
ADVATE |
|
EU/1/03/271 |
26.6.2026 |
||
|
25.6.2026 |
Eliquis |
|
EU/1/11/691 |
26.6.2026 |
||
|
25.6.2026 |
Enhertu |
|
EU/1/20/1508 |
26.6.2026 |
||
|
25.6.2026 |
Erbitux |
|
EU/1/04/281 |
26.6.2026 |
||
|
25.6.2026 |
Eucreas |
|
EU/1/07/425 |
26.6.2026 |
||
|
25.6.2026 |
Eydenzelt |
|
EU/1/24/1895 |
30.6.2026 |
||
|
25.6.2026 |
Lokelma |
|
EU/1/17/1173 |
26.6.2026 |
||
|
25.6.2026 |
Olanzapine Teva |
|
EU/1/07/427 |
26.6.2026 |
||
|
25.6.2026 |
Rimmyrah |
|
EU/1/23/1779 |
26.6.2026 |
||
|
25.6.2026 |
Sugammadex Mylan |
|
EU/1/21/1583 |
26.6.2026 |
||
|
25.6.2026 |
Teysuno |
|
EU/1/11/669 |
29.6.2026 |
||
|
25.6.2026 |
Trimbow |
|
EU/1/17/1208 |
26.6.2026 |
||
|
25.6.2026 |
Truqap |
|
EU/1/24/1820 |
26.6.2026 |
||
|
25.6.2026 |
Yescarta |
|
EU/1/18/1299 |
30.6.2026 |
||
|
25.6.2026 |
Zoledronic acid Accord |
|
EU/1/13/834 |
26.6.2026 |
||
|
26.6.2026 |
Levetiracetam Actavis |
|
EU/1/11/713 |
29.6.2026 |
||
|
26.6.2026 |
Revlimid |
|
EU/1/07/391 |
29.6.2026 |
||
|
26.6.2026 |
Tresiba |
|
EU/1/12/807 |
4.7.2026 |
— Údarú margaíochta a mhodhnú (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Diúltaithe
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
19.6.2026 |
Hetlioz |
|
EU/1/15/1008 |
23.6.2026 |
— Údarú margaíochta a tharraingt siar (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle)
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
12.6.2026 |
Qoyvolma |
|
EU/1/25/1925 |
16.6.2026 |
— Údarú margaíochta a mhodhnú (Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle; Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
5.6.2026 |
CLYNAV |
|
EU/2/16/197 |
8.6.2026 |
||
|
5.6.2026 |
Solensia |
|
EU/2/20/269 |
10.6.2026 |
Aon duine ar mian leis féachaint ar an tuarascáil mheasúnaithe phoiblí maidir leis na táirgí íocshláinte atá i gceist agus na cinntí a bhaineann léi, iarrtar orthu teagmháil a dhéanamh le:
|
European Medicines Agency |
|
Domenico Scarlattilaan 6 |
|
1083 HS Amsterdam |
|
NETHERLANDS |
(1) IO L 136, 30.4.2004, lch. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.
(2) IO L 4, 7.1.2019, lch. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.
ELI: http://data.europa.eu/eli/C/2026/3946/oj
ISSN 1977-107X (electronic edition)